Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
A Multicenter, Double-Blind, Placebo-Controlled Study of 3 Doses of LY2140023 in Patients With DSM-IV-TR Schizophrenia
This study ended early.
Multiple locations, including AichiA Randomized Open Label Study on the Efficacy, Tolerability, and Total Costs of Olanzapine Versus Conventional Antipsychotics in the Treatment of Acute Mania in Sweden
This study ended early.
In DanderydA Placebo- and Positive-Controlled Study of the Electrophysiological Effects on the QT Interval After a Supratherapeutic Dose of LY2140023 in Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Garden Grove
A Post-market Clinical Follow-up Investigation in Healthy Volunteers Measuring Eye Parameters to Verify Performance and Safety of Previct® Drugs for Monitoring of Patients in Treatment of Substance Use Disorder
This study has finished and is no longer accepting participants.
In Leiden
This study evaluated the safety and effectiveness of CYB004 for people with anxiety.
This study has finished and is no longer accepting participants.
Multiple locations, including HollywoodCognitive Remediation of the Ability to Infer Intention of Others in Schizophrenic Patients - A Controlled, Randomized Trial (Phase IIb)
This study ended early.
In Le ChesnayThis study assesses suicidal thoughts.
This study was withdrawn before enrollment.
Remote / onlineAn optimisation trial of an SMS-based, brief intervention after hospitalisation for self-harm, a suicide attempt, or suicidal ideation, targeting proximal risk factors for self-harm and suicide.
This study was withdrawn before enrollment.
Multiple locations, including CamperdownA Multicenter, Randomized, Double Blind, Placebo-controlled, Parallel Group, Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Treatment of Major Depressive Episode Associated With Bipolar I or II Disorder
Current recruitment status is unconfirmed.
In SeoulA Study of Activity Leader to Forest Therapy Campaign in Different Environments Targets on the Participants Which Had Been Infected by SARS-COV-2
This study has finished and is no longer accepting participants.
In TaipeiA Study of Adjunctive Aripiprazole in Participants With Major Depressive Disorder
Read the official source — NCT00095758A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Beverly HillsA Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients
Read the official source — NCT00300846A Multicenter, Comparative, Randomized, Double-Blind, Placebo Controlled Study on the Effect on Weight of Adjunctive Treatment With Aripiprazole in Patients With Schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including GrazWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.